1. Home
  2. NGL vs ATYR Comparison

NGL vs ATYR Comparison

Compare NGL & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGL
  • ATYR
  • Stock Information
  • Founded
  • NGL 1940
  • ATYR 2005
  • Country
  • NGL United States
  • ATYR United States
  • Employees
  • NGL N/A
  • ATYR N/A
  • Industry
  • NGL Natural Gas Distribution
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NGL Utilities
  • ATYR Health Care
  • Exchange
  • NGL Nasdaq
  • ATYR Nasdaq
  • Market Cap
  • NGL 446.2M
  • ATYR 451.3M
  • IPO Year
  • NGL 2011
  • ATYR 2015
  • Fundamental
  • Price
  • NGL $4.13
  • ATYR $4.70
  • Analyst Decision
  • NGL
  • ATYR Strong Buy
  • Analyst Count
  • NGL 0
  • ATYR 6
  • Target Price
  • NGL N/A
  • ATYR $20.20
  • AVG Volume (30 Days)
  • NGL 438.4K
  • ATYR 6.0M
  • Earning Date
  • NGL 08-07-2025
  • ATYR 08-12-2025
  • Dividend Yield
  • NGL N/A
  • ATYR N/A
  • EPS Growth
  • NGL N/A
  • ATYR N/A
  • EPS
  • NGL N/A
  • ATYR N/A
  • Revenue
  • NGL $3,469,186,000.00
  • ATYR N/A
  • Revenue This Year
  • NGL N/A
  • ATYR $551.06
  • Revenue Next Year
  • NGL N/A
  • ATYR $1,874.58
  • P/E Ratio
  • NGL N/A
  • ATYR N/A
  • Revenue Growth
  • NGL N/A
  • ATYR N/A
  • 52 Week Low
  • NGL $2.64
  • ATYR $1.67
  • 52 Week High
  • NGL $5.73
  • ATYR $7.29
  • Technical
  • Relative Strength Index (RSI)
  • NGL 43.74
  • ATYR 42.54
  • Support Level
  • NGL $4.17
  • ATYR $5.46
  • Resistance Level
  • NGL $4.40
  • ATYR $7.29
  • Average True Range (ATR)
  • NGL 0.14
  • ATYR 0.65
  • MACD
  • NGL -0.03
  • ATYR -0.16
  • Stochastic Oscillator
  • NGL 19.51
  • ATYR 8.32

About NGL NGL ENERGY PARTNERS LP Common Units representing Limited Partner Interests

NGL Energy Partners LP is a USA-based firm that owns and operates a vertically integrated energy business. The company's operating segments include Crude Oil Logistics, Water Solutions, and Liquids Logistics. It operates crude oil Logistics, owns pipeline injection stations, and offers services for the treatment and disposal of wastewater generated from crude oil and natural gas production, as well as for the disposal of solids, such as tank bottoms and drilling fluids. The firm also supplies natural gas liquids to retailers, wholesalers, refiners, and petrochemical plants and sells propane and distillates.

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: